ARCHIVES

Zydelig Tablets Approved For Three Blood Cancers

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

Cediranib/Olaparib Combination Nearly Doubles PFS in Phase II

September 26, 2014

Maria Carolina Hinestrosa, EVP of National Breast Cancer Coalition

June 26, 2009

DCT Board to Study Modifications Of Existing Cooperative Group System

June 13, 1986

Book By Clinical Researcher Makes Case For Nationwide Reforms

July 30, 1993

Also FDA clarifies data requirements for phase I IND applications.

April 29, 2005

Mammography Panel Reaches Consensus On Most Issues

September 23, 1977